Matthew J. Jennings
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
Journal: The Journal of clinical investigation
Published: March 02, 2022
The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy.
Journal: Science (New York, N.Y.)
Published: September 13, 2021
Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'.
Journal: Journal of neuromuscular diseases
Published: July 26, 2021
NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.
Journal: Brain : a journal of neurology
Published: July 20, 2021
Intracellular Lipid Accumulation and Mitochondrial Dysfunction Accompanies Endoplasmic Reticulum Stress Caused by Loss of the Co-chaperone DNAJC3.
Journal: Frontiers in cell and developmental biology
Published: May 15, 2021
Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome.
Journal: Orphanet journal of rare diseases
Published: March 23, 2021
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
Journal: Gene therapy
Published: December 17, 2020
Targeted Therapies for Hereditary Peripheral Neuropathies: Systematic Review and Steps Towards a 'treatabolome'.
Journal: Journal of neuromuscular diseases
Published: August 11, 2020
Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency.
Journal: The EMBO journal
Published: April 21, 2020
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.
Journal: Orphanet journal of rare diseases
Published: March 01, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects.
Journal: American journal of human genetics
Published: February 25, 2020
Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients.
Journal: Frontiers in neurology
Published: October 11, 2018
Last Updated: 09/26/2026